[{"name":"MOAB0201 - Impact of rosuvastatin on atherosclerotic progression in people with HIV at moderate cardiovascular risk; A multinational, randomized, double blind, placebo-controlled trial \u003Csmall\u003E(ID 559)\u003C\/small\u003E","mode":"","public":true,"info":{"id":559,"presentation":"MOAB0201 - Impact of rosuvastatin on atherosclerotic progression in people with HIV at moderate cardiovascular risk; A multinational, randomized, double blind, placebo-controlled trial \u003Csmall\u003E(ID 559)\u003C\/small\u003E","session":"MOAB02 - Co-morbidities: No organ left behind \u003Csmall\u003E(ID 86)\u003C\/small\u003E","presenter":"Janine Trevillyan","photo":""},"playlist":[{"name":"","source":"https:\/\/s3.us-west-2.amazonaws.com\/us-cslide-prod-recordings\/ias2019\/86\/v\/559_1c.mp4","source_path":"s3:\/\/us-cslide-prod-recordings\/ias2019\/86\/v\/559_1c.mp4","cover":"https:\/\/s3.us-west-2.amazonaws.com\/us-cslide-prod-recordings\/ias2019\/86\/7CF20755.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.us-west-2.amazonaws.com\/us-cslide-prod-recordings\/ias2019\/86\/v\/559_1c.vtt","thumbnails":"https:\/\/s3.us-west-2.amazonaws.com\/us-cslide-prod-recordings\/ias2019\/86\/v\/559_1c-thumbnails.vtt"}]}]{"provider":"CTI","provider_live":0,"type":1,"code":"7E22Up0aD"}